Madison Avenue Partners LP 13D and 13G filings for Theravance Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 09:53 am Purchase | 2024-09-30 | 13G | Theravance Biopharma, Inc. TBPH | Madison Avenue Partners LP | 9,511,150 19.400% | 999,800 (+11.75%) | Filing |
| 2024-05-03 5:49 pm Purchase | 2024-05-01 | 13G | Theravance Biopharma, Inc. TBPH | Madison Avenue Partners LP | 8,511,350 17.500% | 1,499,124 (+21.38%) | Filing |
| 2023-02-14 09:58 am Purchase | 2022-12-31 | 13G | Theravance Biopharma, Inc. TBPH | Madison Avenue Partners LP | 7,012,226 10.400% | 364,201 (+5.48%) | Filing |
| 2022-02-14 09:43 am Purchase | 2021-12-31 | 13G | Theravance Biopharma, Inc. TBPH | Madison Avenue Partners LP | 6,648,025 9.000% | 2,080,612 (+45.55%) | Filing |
| 2021-09-27 4:46 pm Purchase | 2021-09-15 | 13G | Theravance Biopharma, Inc. TBPH | Madison Avenue Partners LP | 4,567,413 6.200% | 4,567,413 (New Position) | Filing |